ARTICLE | Financial News

ALK-Abelló raises DKK698.9M in private placement

December 8, 2017 9:05 PM UTC

On Dec. 7, ALK-Abelló A/S (CSE:ALK-B) raised DKK698.9 million ($111.5 million) through the sale of 1 million shares at DKK690 in an oversubscribed private placement led by Danske Bank. Other undisclosed investors also participated.

ALK said the funds will help finance its DKK1 billion ($160 million), three-year investment plan, announced Dec. 4, to transform the company into a broader-based allergy company by expanding its core allergy immunotherapy (AIT) business, in particular into North America; extending its tablets franchise to include all “relevant ages;” and introducing new products and services to reach a larger share of the allergy patient population...

BCIQ Company Profiles

ALK-Abello A/S